Ligand validation:6V94

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6V94_GOL_B_2008	70%	52%	0.119	0.935	0.87	1	-	-	0	0	100%	1
6V94_GOL_B_2007	65%	57%	0.112	0.914	0.81	0.84	-	-	0	0	100%	1
6D55_GOL_B_2008	74%	41%	0.106	0.937	1.28	1.02	-	1	0	0	100%	1
6D5J_GOL_B_2008	74%	49%	0.103	0.933	0.91	1.04	-	1	0	0	100%	1
6V9M_GOL_B_2008	72%	46%	0.105	0.927	0.97	1.11	-	1	1	0	100%	1
6D5L_GOL_B_2006	70%	57%	0.111	0.928	0.85	0.81	-	-	0	0	100%	1
6BVJ_GOL_B_2008	68%	50%	0.112	0.924	0.93	1.01	-	1	1	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.